Colangite Biliare Primitiva, ok dell’Aifa to repayment of seladelpar
MILAN (ITALPRESS) – Gilead Sciences announces the admission of reimbursement by the Italian Agency for Pharmaco (AIFA) of seladelpar for the treatment of Colangitis Biliare Primitiva (Primary Biliary Cholangitis, PBC) in combination with ursodesoxylic acid (UDCA) in adults who have […]
Colangite Biliare Primitiva, ok dell’Aifa to repayment of seladelpar Read More »










